1. Alejandria MM, Lansang MA, Dans KF et al. (2002) Intravenous immunoglobulin for treating sepsis and septic shock (Systematic Review CD 001090). In: The Cochrane Library 2. Oxford, Update Software. Siehe auch The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
2. Andersson J, Fehniger T, Björk L, Andersson U (1996) Intravenous immune globulin has effects on superantigen-induced cytokine synthesis. Infusionsther Transfusionsmed 23(Suppl 4): 7–14
3. Andersson JP, Andersson UG (1990) Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 71: 372–376
4. Andersson UG, Björk L, Skansen-Saphir U, Andersson JP (1993) Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 79: 211–216
5. Behre G, Ostermann H, Schedel I et al. (1995) Endotoxin concentrations and therapy with polyclonal IgM-enriched immunoglobulins in neutropenic cancer patients with sepsis syndrome: Pilot study and interim analysis of a randomized trial. Antiinfect Drug Chemother 13:129–134